These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30623278)

  • 21. Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: A population-level study, Japan, 2015-2018.
    Tsuzuki S; Matsunaga N; Yahara K; Shibayama K; Sugai M; Ohmagari N
    Int J Infect Dis; 2021 Jul; 108():119-124. PubMed ID: 33992765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Reg Health Am; 2023 Sep; 25():100561. PubMed ID: 37727594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.
    Slayton RB; Toth D; Lee BY; Tanner W; Bartsch SM; Khader K; Wong K; Brown K; McKinnell JA; Ray W; Miller LG; Rubin M; Kim DS; Adler F; Cao C; Avery L; Stone NT; Kallen A; Samore M; Huang SS; Fridkin S; Jernigan JA
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(30):826-31. PubMed ID: 26247436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly virulent pathogens--a post antibiotic era?
    Domin MA
    Br J Theatre Nurs; 1998 May; 8(2):14-8. PubMed ID: 9677888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012.
    Zacher B; Haller S; Willrich N; Walter J; Abu Sin M; Cassini A; Plachouras D; Suetens C; Behnke M; Gastmeier P; Wieler LH; Eckmanns T
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global geographic trends in antimicrobial resistance: the role of international travel.
    Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study.
    Waterlow NR; Cooper BS; Robotham JV; Knight GM
    PLoS Med; 2024 Mar; 21(3):e1004301. PubMed ID: 38484006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key priorities in the prevention and control of healthcare-associated infection: a survey of European and other international infection prevention experts.
    Dettenkofer M; Humphreys H; Saenz H; Carlet J; Hanberger H; Ruef C; Widmer A; Wolkewitz M; Cookson B
    Infection; 2016 Dec; 44(6):719-724. PubMed ID: 27225779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel, integrated approach for understanding and investigating Healthcare Associated Infections: A risk factors constellation analysis.
    Carestia M; Andreoni M; Buonomo E; Ciccacci F; De Angelis L; De Carolis G; De Filippis P; Di Giovanni D; Emberti Gialloreti L; Fontana C; Guarente L; Magrini A; Mattei M; Moramarco S; Morciano L; Mosconi C; Orlando S; Quintavalle G; Riccardi F; Santoro V; Palombi L
    PLoS One; 2023; 18(3):e0282019. PubMed ID: 36961857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
    Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the WHO Integrated Stewardship Policy on the Control of Methicillin-Resistant Staphyloccus aureus and Third-Generation Cephalosporin-Resistant Escherichia coli: Using a Mathematical Modeling Approach.
    Terefe YA; Kassa SM; Njagarah JBH
    Bull Math Biol; 2022 Aug; 84(9):97. PubMed ID: 35931917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Dare CR; Wares KD; Gould IM
    Lancet Infect Dis; 2015 Dec; 15(12):1438-49. PubMed ID: 26411518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare-acquired infections: prevention strategies.
    Fernando SA; Gray TJ; Gottlieb T
    Intern Med J; 2017 Dec; 47(12):1341-1351. PubMed ID: 29224205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2022.
    Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020.
    Coombs GW; Daley DA; Yee NWT; Shoby P; Mowlaboccus S
    Commun Dis Intell (2018); 2022 Apr; 46():. PubMed ID: 35469556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study.
    De Angelis G; Restuccia G; Venturiello S; Cauda R; Malhotra-Kumar S; Goossens H; Schrenzel J; Tacconelli E
    BMC Infect Dis; 2012 Mar; 12():74. PubMed ID: 22458427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy.
    Sticchi C; Alberti M; Artioli S; Assensi M; Baldelli I; Battistini A; Boni S; Cassola G; Castagnola E; Cattaneo M; Cenderello N; Cristina ML; De Mite AM; Fabbri P; Federa F; Giacobbe DR; La Masa D; Lorusso C; Marioni K; Masi VM; Mentore B; Montoro S; Orsi A; Raiteri D; Riente R; Samengo I; Viscoli C; Carloni R;
    J Hosp Infect; 2018 May; 99(1):8-16. PubMed ID: 29253622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial resistance: it is a global crisis, "a slow tsunami"].
    Capozzi C; Maurici M; Panà A
    Ig Sanita Pubbl; 2019; 75(6):429-450. PubMed ID: 32242168
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.